Pricing updated 2015-12-01. Prices are subject to change without notice.
|Purity||≥99% deuterated forms (d1-
|Formulation||A solution in methanol|
|DEA Exempt Notification||This product is a DEA exempt preparation of a scheduled compound - no special processing required. For larger quantities or alternate sizes, please contact sales.|
WARNING - This product is not for human or veterinary use.
|Shipping||Wet ice in continental US; may vary elsewhere|
Download Product Insert 104 Kb PDF
Download Safety Data Sheet (SDS) 33 Kb PDF
View our Base Peak Identification Tool
View our Flipbook Identification Tool
View the Cayman Structure Database for chemical structure definitions for many Cayman products
View the Cayman Spectral Library (CSL) for ChemStation-searchable GCMS spectra of many of Caymans emerging forensic drug standards
Separate multiple batch numbers with commas
Melvin, L.S., Milne, G.M., Johnson, M.R., et al. Structure-
2. Compton, D.R., Johnson, M.R., Melvin, L.S., et al. Pharmacological profile of a series of bicyclic cannabinoid analogs: Classification as cannabimimetic agents. J Pharmacol Exp Ther 260(1) 201-209 (1992).
It appears that there is a heterogenous mixture of deuterated species in your deuterated standards; is this normal?
Yes, this is typical of our deuterated products. Our deuterated products contain less than 1 % d0. However, the labeled compounds are not 100% of the deuterated form listed on our product insert. For example, upon analysis of 2-arachidonoyl glycerol-d8 it is expected to see masses associated with the d7, d6, d5 etc.
We offer you the deep and diverse knowledge of more than 100 in-house scientists and the expertise that comes from more than three decades of designing and developing the tools to advance biomedical research.
Cayman is know as a partner to scientists worldwide, responding to your needs with services in: